S. Ganiatsas et al., SEK1 DEFICIENCY REVEALS MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE CROSSREGULATION AND LEADS TO ABNORMAL HEPATOGENESIS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(12), 1998, pp. 6881-6886
SEK1 (MKK4/JNKK) is a mitogen-activated protein kinase activator that
has been shown to participate in vitro in two stress-activated cascade
s terminating with the SAPK and p38 kinases. To define the role of SEK
1 in vivo, we studied stress-induced signaling in SEK1(-/-) embryonic
stem and fibroblast cells and evaluated the phenotype of SEK1(-/-) mou
se embryos during development. Studies of SEK1(-/-) embryonic stem cel
ls demonstrated defects in stimulated SAPK phosphorylation but not in
the phosphorylation of p38 kinase. In contrast, SEK1(-/-) fibroblasts
exhibited defects in both SAPK and p38 phosphorylation, demonstrating
that crosstalk exists between the stress-activated cascades. Tumor nec
rosis factor LY and interleukin 1 stimulation of both stress-activated
cascades are severely affected in the SEK1(-/-) fibroblast cells. SEK
1 deficiency leads to embryonic lethality after embryonic day 12.5 and
is associated with abnormal liver development, This phenotype is simi
lar to c-jun null mouse embryos and suggests that SEK1 is required for
phosphorylation and activation of c-jun during the organo-genesis of
the liver.